ExploreOutcomeriboflavin concentration in breastmilk
Outcome

riboflavin concentration in breastmilk

Also known as: riboflavin (vitamin B2) concentration in breastmilk
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (27)

None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81
None
adverse

Flash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.

Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81

Size: 0.59 CI: 95% CI 0.44 to 0.81

Papers (1)